|
Quality report cards -- how does your cancer care rate?
From Spotlight on Health Aug./Sept. 2006
Coborn Cancer Center monitors indicators and outcomes, and compares results to national data.
In simpler terms, at Coborn Cancer Center, quality means that a patient who has abnormal results from a mammogram is scheduled for a follow-up mammogram in approximately six days -- compared to the national average of 20 days.
Quality means a patient obtains the most advanced treatment options as anywhere in the country. |
You’ve been told to do your homework to ensure
that you receive the best care for your cancer treatment,
but how do you measure quality?
|
Eighty-eight percent of Coborn Cancer Center's prostate cancer patients are diagnosed in the earlier stages of the disease (Stage I or II) compared to the national average of 81 percent. Statistics show earlier detection results in higher survival rates.
Quality means that a dedicated breast center is located in close proximity to the cancer center -- all under one roof at the CentraCare Health Plaza. A case coordinator sets up and helps to navigate your care plan. And, a breast cancer patient receives the highest quality care in a patient-friendly facility.
Coborn Cancer Center, a service of St. Cloud Hospital and CentraCare Clinic, provides outstanding clinical outcomes and a superior patient experience.
Breast Cancer Quality Indicators
Topic |
Notes |
SCH average |
National average |
Time to diagnostic mammogram
|
Patients receive a phone call (same or next day) after an abnormal finding on screening mammogram to schedule for extra views |
6 days 1 |
20 days 1 |
| Time to biopsy |
92% of patients receive biopsy within 5 days |
8.4 days1 |
19 days1 |
| Time from biopsy results to surgery |
Individualized care as fast or slow at the patient needs |
6-9 days 1 |
8.1 days 1 |
Needle biopsy rate, stereo or ultrasound
|
Percent of patients receiving stereo or ultrasound biopsy versus surgical biopsy |
95% 1 |
50% 1 |
| Sentinel lymph node biopsy utilization |
Percent of eligible breast cancer patient undergoing sentinel node biopsy |
100% 2 |
100% 1 |
| Pathology turn-around time: biopsy |
Availability of results |
1.6 days 2 |
3-4 days 1 |
| Pathology turn-around time: final surgery |
Availability of results |
1.7 days 2 |
3-4 days 1 |
| Surgical breast conservation rate |
Percent of patients receiving breast conservation surgery (lumpectomy/partial mastectomy vs. complete mastectomy) |
83% 2 |
65% 1 |
| Survival rate |
Five year relative survival rate by stage at diagnosis |
In-situ 100% 3
Local 100%
Regional 86.3%
Distant 32.7% |
In-situ 100% 2
Local 97.2%
Regional 81.3%
Distant 26.1% |
St. Cloud Hospital benchmarks: Jan-Dec 2004
1Penrad QC
2Chart Review
3Tumor Registry – NCI |
National benchmarks:
1Oncology Roundtable 2004
2SEER (1995-2001) |
Prostate Cancer Quality Indicators
Topic |
Notes |
SCH average |
National average |
Patient stage at diagnosis
|
The stage at which the patient is diagnosed |
Early stage
(I, II) 88%*
Late stage (III, IV, unknown) 12%*
*numbers are rounded |
Early stage
(I, II) 81%*
Late stage (III, IV, unknown) 18%*
*numbers are rounded |
Operative blood loss
|
Average blood loss during radical prostatectomy surgery |
873 mL 1 |
1,000 mL 1 |
Work up prior to treatment options
|
Percent of patients who had a PSA (prostate specific antigen), DRE (digital rectal exam), Gleason score prior to treatment. |
100% 2 |
100% 2 |
St. Cloud Hospital benchmarks: Jan-Dec 2004
1Cancer Registry 2003-2004
2Adult & Pediatric Urology |
National benchmarks:
1Oncology Roundtable 2004, 2005
2Adult & Pediatric Standard of Practice |
Prostate Cancer Treatment Options
|
St. Cloud Hospital |
Mayo Clinic |
University of MN |
| Radical Prostatectomy Surgery |
|
|
|
| Minimal Invasive Surgery (DiVinci Robotic) |
|
|
|
| Cryosurgery |
|
|
|
| External Beam Radiation |
|
|
|
| Prostate Seed Implant |
|
|
|
| Hormone Therapy |
|
|
|
| Watchful Waiting |
|
|
|
| Access to Prostate Clinical Trials |
|
|
|
Learn more about Coborn Cancer Center.
|
Programs & Services
For Women
For Men
For Patients
For the Community
